Medical Microinstruments, Inc. (MMI)

MMI has developed the first teleoperated robotic platform for suturing in open surgery with wristed microinstruments. It offers the surgeon motion scaling and tremor elimination and aims to facilitate existing procedures as well as enable new ones in the domain of microsurgery, from post-oncological and trauma reconstructions to ophthalmology, organ transplantation and pediatric surgery. The Company's mission is to help more surgeons around the world to offer more advanced procedures, while reducing costs for patients, hospitals and for society at large. The Symani System is authorized for use in the U.S. by the FDA and is a CE Marked medical device in Europe.